Xiong-Gang Yang1,2, Jiang-Tao Feng2, Feng Wang2, Xin He1, Hao Zhang2, Li Yang2, Hao-Ran Zhang2, Yong-Cheng Hu3. 1. Department of Bone Oncology, Tianjin Hospital, No. 406, Jiefang Southern Road, Hexi District, Tianjin, 300211, China. 2. Graduate School, Tianjin Medical University, Tianjin, 300070, China. 3. Department of Bone Oncology, Tianjin Hospital, No. 406, Jiefang Southern Road, Hexi District, Tianjin, 300211, China. huycdoctor@163.com.
Abstract
INTRODUCTION: The primary goal of treatment in spinal metastasis is typically to extend patients' lifespan as much as possible, and optimally to relieve the symptoms and so improve quality of life. It is crucial to avoid over- or under-treatment, according to each patient's individual situation. Thus, this study aimed to identify significant prognostic factors for patients living with metastatic spine disease, and create a new nomogram for the prediction of survival rates. METHODS: Data from patients who had undergone operations for spinal metastasis between 2005 and 2016 were retrieved retrospectively, and randomized into training (70%) and validation groups (30%). A selection of pre-operative factors was analyzed using univariable and multivariable COX model for the training group. A nomogram was then developed using significant predictors in multivariable analysis. Accuracy was validated using a concordance index (C-index) and calibration curve for the training and validation groups, respectively. RESULTS: A total of 244 participants were enrolled, including 171 in the training group and 73 in the validation group. Primary tumor, Frankel Grade, Karnofsky Performance Score (KPS) and adjuvant therapy were found to be significant for predicting survival rates. A nomogram was developed by utilizing these predictors. The C-indexes for the two groups were 0.711 and 0.703 respectively. Moreover, a favorable consistency between the predicted and actual survival probabilities was demonstrated using calibration curves. CONCLUSIONS: A user-friendly nomogram model for facilitating medical procedures during clinical encounters was established to aid clinical decision making for individual patients.
RCT Entities:
INTRODUCTION: The primary goal of treatment in spinal metastasis is typically to extend patients' lifespan as much as possible, and optimally to relieve the symptoms and so improve quality of life. It is crucial to avoid over- or under-treatment, according to each patient's individual situation. Thus, this study aimed to identify significant prognostic factors for patients living with metastatic spine disease, and create a new nomogram for the prediction of survival rates. METHODS: Data from patients who had undergone operations for spinal metastasis between 2005 and 2016 were retrieved retrospectively, and randomized into training (70%) and validation groups (30%). A selection of pre-operative factors was analyzed using univariable and multivariable COX model for the training group. A nomogram was then developed using significant predictors in multivariable analysis. Accuracy was validated using a concordance index (C-index) and calibration curve for the training and validation groups, respectively. RESULTS: A total of 244 participants were enrolled, including 171 in the training group and 73 in the validation group. Primary tumor, Frankel Grade, Karnofsky Performance Score (KPS) and adjuvant therapy were found to be significant for predicting survival rates. A nomogram was developed by utilizing these predictors. The C-indexes for the two groups were 0.711 and 0.703 respectively. Moreover, a favorable consistency between the predicted and actual survival probabilities was demonstrated using calibration curves. CONCLUSIONS: A user-friendly nomogram model for facilitating medical procedures during clinical encounters was established to aid clinical decision making for individual patients.
Authors: Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young Journal: Lancet Date: 2005 Aug 20-26 Impact factor: 79.321
Authors: E A Enkaoua; L Doursounian; G Chatellier; F Mabesoone; T Aimard; G Saillant Journal: Spine (Phila Pa 1976) Date: 1997-10-01 Impact factor: 3.468
Authors: D Rades; S Huttenlocher; J N Evers; A Bajrovic; J H Karstens; V Rudat; S E Schild Journal: Strahlenther Onkol Date: 2012-02-16 Impact factor: 3.621
Authors: Ahmedin Jemal; Limin X Clegg; Elizabeth Ward; Lynn A G Ries; Xiaocheng Wu; Patricia M Jamison; Phyllis A Wingo; Holly L Howe; Robert N Anderson; Brenda K Edwards Journal: Cancer Date: 2004-07-01 Impact factor: 6.860
Authors: L Leon Chen; Matthew E Nolan; Melvin J Silverstein; Martin C Mihm; Arthur J Sober; Kenneth K Tanabe; Barbara L Smith; Jerry Younger; James S Michaelson Journal: Cancer Date: 2009-11-01 Impact factor: 6.860